Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Interactive Robotic Therapy Helps Stroke Victims Regain Limb Function

By HospiMedica International staff writers
Posted on 19 May 2010
Stroke patients can regain some ability to use their arms using a robot that delivers high-intensity response-controlled physical therapy, even if the stroke had occurred years earlier. More...


Researchers at the Massachusetts Institute of Technology (MIT, Cambridge, USA) developed the MIT-Manus system, which is based on the principal that it is important for stroke patients to make a conscious effort during physical therapy. Patients using the system grasp a joystick-like handle connected to a computer monitor that displays tasks similar to those in simple video games. In a typical task, the subject attempts to move the robot handle toward a moving or stationary target shown on the computer monitor. If the person starts moving in the wrong direction or does not move, the robotic arm gently nudges the patient's arm, wrist, or hand as he or she tries to make specific movements, helping the brain form new connections that will eventually help them "relearn” how to move the limb on their own.

A study with the system conducted at four U.S. Veterans Affairs (VA) hospitals found that patients who used the MIT robotic devices for 12 weeks experienced a small but significant gain in arm function, demonstrated again at 36 weeks. A control group of patients who received high-intensity therapy from a physical therapist, which matched the number and intensity of the robot movements--developed specifically for comparison purposes for this study--showed similar improvements. However, this high-intensity, interactive physical therapy exacts physical demands on the therapist that make it unlikely that it will ever be widely used. The researchers are also studying whether the MIT-Manus system could help patients with cerebral palsy, multiple sclerosis (MS), and spinal cord injury. The study comparing the two therapies was published in the April 16, 2010, online issue of the New England Journal of Medicine (NEJM).

"If you can get a therapist to work at that pace with a patient, certainly the benefits are roughly the same, and we showed this benefit when we designed this intensive comparison group, but it's not practical,” said MIT-Manus system principal developer Hermano Igo Krebs, Ph.D., of MIT's department of mechanical engineering. "Robotics and automation technology are ideal for this kind of highly repetitive tasks. We're using robotic technology to create a tool for the therapist to afford this kind of high-intensity therapy while maintaining the therapist supervisory role, deciding what is right for a particular patient.”

Related Links:

Massachusetts Institute of Technology




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.